INOTEK PHARMACEUTICALS CORP - COM (ITEK)

CUSIP: 45780V102

Q4 2016 13F Holders as of 31 Dec 2016

Type / Class
Equity / COM
Total 13F shares
17,806,802
Share change
-820,774
Total reported value
$108,615,996
Put/Call ratio
70%
Price per share
$6.10
Number of holders
81
Value change
-$10,162,154
Number of buys
41
Number of sells
34

Quarterly Holders Quick Answers

What is CUSIP 45780V102?
CUSIP 45780V102 identifies ITEK - INOTEK PHARMACEUTICALS CORP - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of INOTEK PHARMACEUTICALS CORP - COM (ITEK) as of Q4 2016

As of 31 Dec 2016, INOTEK PHARMACEUTICALS CORP - COM (ITEK) was held by 81 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 17,806,802 shares. The largest 10 holders included RHO CAPITAL PARTNERS INC, JENNISON ASSOCIATES LLC, ORBIMED ADVISORS LLC, GREAT POINT PARTNERS LLC, FRANKLIN RESOURCES INC, PRICE T ROWE ASSOCIATES INC /MD/, BlackRock Fund Advisors, MILLENNIUM MANAGEMENT LLC, ADAGE CAPITAL PARTNERS GP, L.L.C., and SENZAR ASSET MANAGEMENT, LLC. This page lists 81 institutional shareholders reporting positions in this security for the Q4 2016 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.